During the past decade, Masimo Corporation conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 23 clinical trials were completed, i.e. on average, 95.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 18 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Masimo Corporation" are "Healthy" (24 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Masimo Corporation" in a lesser frequency.

Most popular intervention types in "Masimo Corporation" are "Device" (25 trials). Other intervention types were less common.

The name of intervention was led by "INVSENSOR00025" (2 trials), "INVSENSOR00029" (2 trials), "Hemoglobin Sensor ((Rainbow Reusable DCI, DCIP))" (1 trials), "INVSENSOR00006" (1 trials) and "INVSENSOR00012" (1 trials). Other intervention names were less common.

The vast majority of trials in "Masimo Corporation" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Masimo Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Masimo Corporation, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Masimo Corporation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 16 trials that are defined as “Not Applicable".